165 related articles for article (PubMed ID: 35794782)
41. Ticagrelor Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Rats by the Inhibition of TGF-β1/Smad3 and PI3K/AKT/mTOR Pathways.
Wanas H; El Shereef Z; Rashed L; Aboulhoda BE
Curr Mol Pharmacol; 2022; 15(1):227-238. PubMed ID: 33563204
[TBL] [Abstract][Full Text] [Related]
42. Chlorogenic Acid Inhibited Epithelial-Mesenchymal Transition to Treat Pulmonary Fibrosis through Modulating Autophagy.
Mao X; Xie X; Ma J; Wei Y; Huang Z; Wang T; Zhu J; Wang Y; Zhao H; Hua J
Biol Pharm Bull; 2023; 46(7):929-938. PubMed ID: 37394644
[TBL] [Abstract][Full Text] [Related]
43. Calcitriol inhibits bleomycin-induced early pulmonary inflammatory response and epithelial-mesenchymal transition in mice.
Tan ZX; Chen YH; Xu S; Qin HY; Zhang C; Zhao H; Xu DX
Toxicol Lett; 2016 Jan; 240(1):161-71. PubMed ID: 26520185
[TBL] [Abstract][Full Text] [Related]
44. Sparganii Rhizoma alleviates pulmonary fibrosis by inhibiting fibroblasts differentiation and epithelial-mesenchymal transition mediated by TGF-β1/ Smad2/3 pathway.
Liu J; Gao D; Ding Q; Zhang B; Zhu W; Shi Y
J Ethnopharmacol; 2023 Jun; 309():116305. PubMed ID: 36878395
[TBL] [Abstract][Full Text] [Related]
45. S-Allylmercaptocysteine attenuates Bleomycin-induced pulmonary fibrosis in mice via suppressing TGF-β1/Smad and oxidative stress pathways.
Li C; Sun X; Li A; Mo M; Zhao Z
Int Immunopharmacol; 2020 Feb; 79():106110. PubMed ID: 31874367
[TBL] [Abstract][Full Text] [Related]
46. Galangin ameliorated pulmonary fibrosis in vivo and in vitro by regulating epithelial-mesenchymal transition.
Wang L; Liu H; He Q; Gan C; Li Y; Zhang Q; Yao Y; He F; Ye T; Yin W
Bioorg Med Chem; 2020 Oct; 28(19):115663. PubMed ID: 32912432
[TBL] [Abstract][Full Text] [Related]
47. Hydroxysafflor Yellow A Attenuates Bleomycin-induced Pulmonary Fibrosis in Mice.
Jin M; Wu Y; Wang L; Zang B; Tan L
Phytother Res; 2016 Apr; 30(4):577-87. PubMed ID: 26777519
[TBL] [Abstract][Full Text] [Related]
48. Berberine attenuates epithelial mesenchymal transition in bleomycin-induced pulmonary fibrosis in mice via activating A
Ahmedy OA; Kamel MW; Abouelfadl DM; Shabana ME; Sayed RH
Life Sci; 2023 Jun; 322():121665. PubMed ID: 37028546
[TBL] [Abstract][Full Text] [Related]
49. Andrographolide attenuates epithelial-mesenchymal transition induced by TGF-β1 in alveolar epithelial cells.
Li J; Liu J; Yue W; Xu K; Cai W; Cui F; Li Z; Wang W; He J
J Cell Mol Med; 2020 Sep; 24(18):10501-10511. PubMed ID: 32705806
[TBL] [Abstract][Full Text] [Related]
50. Inhibition of mTOR ameliorates bleomycin-induced pulmonary fibrosis by regulating epithelial-mesenchymal transition.
Han Q; Lin L; Zhao B; Wang N; Liu X
Biochem Biophys Res Commun; 2018 Jun; 500(4):839-845. PubMed ID: 29704504
[TBL] [Abstract][Full Text] [Related]
51. Longitudinal assessment of bleomycin-induced pulmonary fibrosis by evaluating TGF-β1/Smad2, Nrf2 signaling and metabolomic analysis in mice.
Washimkar KR; Tomar MS; Kulkarni C; Verma S; Shrivastava A; Chattopadhyay N; Mugale MN
Life Sci; 2023 Oct; 331():122064. PubMed ID: 37657527
[TBL] [Abstract][Full Text] [Related]
52. Anthelmintic nitazoxanide protects against experimental pulmonary fibrosis.
Chen XY; Dong YC; Yu YY; Jiang M; Bu WJ; Li P; Sun ZJ; Dong DL
Br J Pharmacol; 2023 Dec; 180(23):3008-3023. PubMed ID: 37428102
[TBL] [Abstract][Full Text] [Related]
53. Preventive Effects of Rhodiola rosea L. on Bleomycin-Induced Pulmonary Fibrosis in Rats.
Zhang K; Si XP; Huang J; Han J; Liang X; Xu XB; Wang YT; Li GY; Wang HY; Wang JH
Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27271612
[TBL] [Abstract][Full Text] [Related]
54. Induced Pluripotent Stem Cells Inhibit Bleomycin-Induced Pulmonary Fibrosis in Mice through Suppressing TGF-β1/Smad-Mediated Epithelial to Mesenchymal Transition.
Zhou Y; He Z; Gao Y; Zheng R; Zhang X; Zhao L; Tan M
Front Pharmacol; 2016; 7():430. PubMed ID: 27895584
[TBL] [Abstract][Full Text] [Related]
55. Amifostine ameliorates bleomycin-induced murine pulmonary fibrosis via NAD
Guo F; Xu F; Li S; Zhang Y; Lv D; Zheng L; Gan Y; Zhou M; Zhao K; Xu S; Wu B; Deng Z; Fu P
Eur J Med Res; 2024 Jan; 29(1):68. PubMed ID: 38245795
[TBL] [Abstract][Full Text] [Related]
56. Peptide PD29 treats bleomycin-induced pulmonary fibrosis by inhibiting the TGF-β/smad signaling pathway.
Sun Q; Hu J; Yu P; Zhu Z; Yu R; Ge C; Li C; Wu G; Lin B; Liu G; Liu M; Bian H; Xu H; Jia S
Exp Lung Res; 2019; 45(5-6):123-134. PubMed ID: 31210057
[TBL] [Abstract][Full Text] [Related]
57. Kurarinone Attenuates BLM-Induced Pulmonary Fibrosis via Inhibiting TGF-β Signaling Pathways.
Park SJ; Kim TH; Lee K; Kang MA; Jang HJ; Ryu HW; Oh SR; Lee HJ
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445094
[TBL] [Abstract][Full Text] [Related]
58. Low-dose paclitaxel ameliorates pulmonary fibrosis by suppressing TGF-β1/Smad3 pathway via miR-140 upregulation.
Wang C; Song X; Li Y; Han F; Gao S; Wang X; Xie S; Lv C
PLoS One; 2013; 8(8):e70725. PubMed ID: 23967091
[TBL] [Abstract][Full Text] [Related]
59. Novel RAS inhibitor 25-O-methylalisol F attenuates epithelial-to-mesenchymal transition and tubulo-interstitial fibrosis by selectively inhibiting TGF-β-mediated Smad3 phosphorylation.
Chen H; Yang T; Wang MC; Chen DQ; Yang Y; Zhao YY
Phytomedicine; 2018 Mar; 42():207-218. PubMed ID: 29655688
[TBL] [Abstract][Full Text] [Related]
60. Zingerone ameliorates oxidative stress and inflammation in bleomycin-induced pulmonary fibrosis: modulation of the expression of TGF-β1 and iNOS.
Gungor H; Ekici M; Onder Karayigit M; Turgut NH; Kara H; Arslanbas E
Naunyn Schmiedebergs Arch Pharmacol; 2020 Sep; 393(9):1659-1670. PubMed ID: 32377772
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
